The role of the epithelial cell in Escherichia coil induced neutrophil migration into the urinary tract

European Respiratory Journal

Volumn 9, Issue 8, 1996, Pages 1713-1728

  Agace, W W ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cell adhesion molecules; Chemokines; Epithelial cells; Mucosal; Neutrophils

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 8; SELECTIN;

BACTERIAL COLONIZATION; ESCHERICHIA COLI; HUMAN; IMMUNOMODULATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION; UROTHELIUM;

EID: 0029782308     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09081713     Document Type: Review

References (161)

1. Muller W, Weigl S, Deng X, Phillips D. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449-460.
2. Newman P, Berndt M, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin superfamily. Science 1990; 247: 1219-1222.
3. Muller W, Ratti C, McDonnell S, Cohn Z. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 1989; 170: 399-414.
4. Stockinger H, Gadd S, Ether R, et al. Molecular characterisation and functional analysis of the leukocyte surface protein CD31. J Immunol 1990; 145: 3889-3897.
5. Lawrence M, Springer T. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859-873.
6. Lawrence M, Springer T. Neutrophils roll on E-selectin. J Immunol 1993; 151: 6338-6346.
7. Ley K, Bullard D, Arbonés M, et al. Sequential rolling of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 1995; 181: 669-675.
8. Nelson R, Dolich S, Aruffo A, Cecconi O, Bevilacqua M. High affinity oligosaccharide ligands for E-selectin. J Clin Invest 1993; 91: 1157-1166.
9. Bevilacqua M, Nelson R. Selectins. J Clin Invest 1993; 91: 379-387.
10. McEver R, Beckstead J, Moore K, Marshall Carlson L, Bainton D. GMP-140, a platelet alpha granule membrane protein, is also synthesized by vascular endothelial cells and is localised in Weibel-Palade bodies. J Clin Invest 1989; 84: 92-99.
11. Hattori R, Hamilton K, Fugate R, McEver R, Sims P. Stimulated secretion of endothelial vonWillebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768.
12. Bonfanti R, Furie B, Furie B, Wagner D. PADGEM (GMP-140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 1989; 73: 1109-1112.
13. Geng J, Bevilacqua M, Moore K, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990; 343: 757-760.
14. Lorant D, Topham M, Whatley R, et al. In-flammatory roles of P-selectin. J Clin Invest 1993; 92: 559-570.
15. Bullard D, Qin L, Lorenzo I, et al. P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J Clin Invest 1995; 95: 1782-1788.
16. Bevilacqua M, Stengelin S, Gimbrone M, Seed B. Endothelial leukocyte adhesion molecule 1 : an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-1164.
17. Pober J, Gimbrone M, Lapierre L, Mendrick D, Rothlein R, Springer T. Overlapping patterns of activation of human endothelial cell by interleukin-1, tumor necrosis factor, and immune Interferon. J Immunol 1986; 137: 1893-1896.
18. Lo S, Lee S, Ramos R, et al. Endothelial leucocyte adhesion molecule-1 stimulates the adhesive activity of CR3 (GD11b/CD18, Mac-1, αmβ2) on human neutrophils. J Exp Med 1991; 173: 1493-1500.
19. Gundel R, Wegner C, Torcellini C, et al. Endothelial-leucocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late phase airway obstruction in monkeys. J Clin Invest 1991; 88: 1407-1411.
20. Mulligan M, Varani S, Dame M, et al. Role of endothelial-leucocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 1991; 88: 1396-1406.
21. Spertini O, Luscinskas FW, Kansas GS, et al. Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991; 147: 2565-2573.
22. Kishimoto T, Jutila M, Berg E, Butcher E. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989; 245: 1238-1241.
23. Spertini O, Kansas G, Munro J, Griffin J, Tedder T. Regulation of leucocyte migration by activation of the leucocyte adhesion molecule-1 (LAM-l)selectin. Nature 1991; 349: 691-693.
24. Crockett-Torabi E, Sulenbarger B, Wayne Smith C, Fantone J. Activation of human neutrophils through L-selectin and Mac-1 molecules. J Immunol 1995; 154: 2291-2302.
25. Mulligan M, Miyasaka M, Tamatani T, Jones M, Ward P. Requirements for L-selectin in neutrophil-mediated lung injury. J Immunol 1992; 152: 832-840.
26. Watson S, Fennie C, Lasky L. Neurophil influx into an inflammatory site inhibited by a soluble homing receptor-IgG chimera. Nature 1991; 349: 164-167.
27. Wayne Smith C, Martin S, Rothlein R, Toman C, Anderson D. Co-operative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989; 83: 2008-2017.
28. Zimmerman G, McIntyre T. Neutrophil adherence to human endothelium occurs by CDw18 (Mol, MAC-1/LFA-l/GP-150,95) glycoprotein-dependent and independent mechanisms. J Clin Invest 1988; 81: 531-537.
29. Stacker S, Springer T. Leucocyte integrin p 159,95 (CD11c/CD18) functions as an adhesion molecule binding to counterreceptor on stimulated endothelium. J Immunol 1991; 146: 648-655.
30. Bainton D, Miller L, Kishimoto T, Springer T. Leucocyte adhesion receptors are stored in peroxidase negative granules of human neutrophils. J Exp Med 1987; 166: 1641-1653.
31. Todd III R, Arnout M, Rosin R, et al. Subcellular localization of Mol (Mol alpha; formerly gp110), a surface glycoprotein associated with neutrophil adhesion. J Clin Invest 1984; 74: 1280-1290.
32. Miller L, Bainton D, Borregaard N, Springer T. Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest 1987; 1987: 535-544.
33. Segeløv H, Kjeldsen L, Diamond M, Springer T, Borregaard N. Subcellular localization and dynamics of Mac-1 (αMβ2) in human neutrophils. J Clin Invest 1993; 92: 1467-1476.
34. Vedder N, Harlan J. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J Clin Invest 1988; 81: 676-682.
35. Hughes B, Hollers J, Crockett-Torabi E, Wayne Smith C. Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion. J Clin Invest 1992; 90: 1687-1696.
36. Hibbs M, Jakes S, Stacker S, Wallace R, Springer T. The cytoplasmic domain of the integrin lymphocyte function-associated antigen 1 β subunit: sites required for binding to intercellular adhesion molecule-1 and the phorbal ester-stimulated phosphorylation site. J Exp Med 1991; 174: 1227-1238.
37. Hibbs M, Xu H, Sucker S, Springer T. Regulation of adhesion to ICAM-1 by the cytoplasmic domain of LFA-1 integrin beta subunit. Science 1991; 251: 1611-1613.
38. Kuijpers T, Mul E, Blom M, Kovach N, et al. Freezing adhesion molecules in a state of high avidity binding blocks eosinophil migration. J Exp Med 1993; 178: 279-284.
39. Doerschuk C, Winn R, Coxson H, Harlan J. GD18-dependent and independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol 1990; 144: 2327-2333.
40. Conlan W, North R. Listeria monocytogenes, but not Salmonella typhimurium, elicits a CD18-independent mechanism of neutrophil extravasation into the murine peritoneal cavity. Infect Immun 1994; 62: 2702-2706.
41. Fougerolles A, Stacker S, Schwarting R, Springer T. Characterization of ICAM-2 and evidence for a third counterreceptor for LFA-1. J Exp Med 1991; 174: 253-267.
42. Diamond M, Staunton D, de Fougerolles A, et al. ICAM-1 (CD54), a counterreceptor for Mac-1 (CD11b/CD18). J Cell Biol 1990; 111: 3129-3139.
43. Staunton D, Dustin M, Erickson H, Springer T. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990; 61: 243-245.
44. Xie J, Li R, Kotovuori P, Vermot-Desroches C, et al. Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain. J Immunol 1995; 155: 3619-3628.
45. Staunton D, Dustin M, Springer T. Fuctional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 1989; 339: 61-64.
46. Nortamo P, Rui L, Renkonen R, et al. The expression of intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol 1991; 21: 2629-2632.
47. Mulligan M, Wilson G, Todd R, et al. Role of βl, β2 integrins and ICAM-1 in lung injury after deposition of IgG and IgA immune complexes. J Immunol 1993; 150: 2407-2417.
48. Mulligan M, Wayne Smith C, et al. Role of leucocyte adhesion molecules in complement-induced lung injury. J Immunol 1993; 150: 2401-2406.
49. Horgan M, Ge M, Gu J, Rothlein R, Malik A. Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol 1991; 261: H1578.
50. Sligh J, Ballantyne C, Rich S, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule-1. Proc Natl Acad Sci 1993; 90: 8529-8533.
51. Xu H, Gonzales J, St. Pierre Y, et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule-1 deficient mice. J Exp Med 1994; 180: 95-109.
52. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994; 55: 97-179.
53. dark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M. Platelet factor-4 binds to interleukin-8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci 1993; 90: 3574-3577.
54. Yoshimura T, Robinson E, Appella E, et al. Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino terminal sequence. Mol Immunol 1989; 26: 87-93.
55. Van Damme J, Van Beeumen J, Conings R, Decock B, Billiau A. Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin. Eur J Biochem 1989; 181: 337-344.
56. Lindley I, Aschauer H, Seifert J, et al. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci 1988; 85: 9199-9203.
57. Gimbrone MJ, Obin MS, Brock AF, et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989; 246: 1601-1603.
58. Nakagawa H, Hatakeyama S, Ikesue A, Miyai H. Generation of interleukin-8 by plasmin from AVLPR-interleukin-8, the human fibroblast-derived neutrophil chemotactic factor. FEBS Lett 1991; 282: 412-414.
59. Hébert C, Luscinskas F, Kiely J, et al. Endothelial and leukocyte forms of IL-8: conversion of thrombin and interactions with neutrophils. J Immunol 1990; 145: 3033-3040.
60. Nourshargh S, Perkins J, Showell H, Matsushima K, Williams T, Collins P. A comparative study of the neutrophil stimulatory activity in vitro and proinflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8. J Immunol 1992; 148: 106-111.
61. Baldwin E, Weber I, St. Charles R, et al. Crystal structure of interleukin-8: symbiosis of NMR and crystallography. Proc Natl Acad Sci 1991; 88: 502-506.
62. Clore G, Appella E, Yamada M, Matsushima K, Gronenborn A. Three-dimensional structure of interleukin 8 in solution. Biochem J 1990; 29: 1689-1696.
63. Rajarathnam K, Sykes B, Kay C, et al. Neutrophil activation by monomeric interleukin-8. Science 1994; 254: 90-92.
64. Paolini J, Willard D, Consler T, Luther M, Krangel M. The chemokines, IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J Immunol 1994; 153: 2704-2717.
65. Yoshimura T, Matsushima K, Oppenheim J, Leanard E. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukoctes: partial characterisation and separation from interleukin-1 (IL-1). J Immunol 1987; 139: 788-793.
66. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167: 1547-1559.
67. Brandt E, Peterson F, Flad H. Recombinant tumor necrosis factor-α potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J Immunol 1992; 149: 1356-1364.
68. 2+)i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/MGSA. J Leukoc Biol 1991; 50: 279-286.
69. Willems J, Joniau M, Cinque S, van Damme J. Human granulocyte chemotactic peptide (IL-8) as a specific neutrophil degranulator: comparison with other monokines. Immunology 1989; 67: 540-542.
70. Detmers PA, Lo SK, Olsen EE, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein-l/interleukin-8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990; 171: 1155-1162.
71. 4, tumour necrosis factor, and formyl-methionyl-leucyl-phenylalanine. J Exp Med 1995; 181: 1763-1772.
72. Huber A, Kunkel S, Todd R, Weiss S. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991; 254: 99-102.
73. Colditz I, Zwahlen R, Dewald B, Baggiolini M. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide from human monocytes. Am JPathol 1989; 134: 755-760.
74. Colditz IG, Zwahlen RD, Baggiolini M. Neutrophil accumulation and plasma leakage induced in vivo by neutrophil-activating peptide-1. J Leukoc Biol 1990; 48: 129-137.
75. Hechtman D, Cybulsky M, Fuchs H, Baker J, Gimbrone M. Intravascular IL-8: inhibitor of polymorphonuclear leukocte accumulation at sites of acute inflammation. J Immunol 1991; 147: 883-892.
76. Simonet W, Hughes T, Nguyen H, Trebasky L, Danilenko D, Medlock E. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 1994; 94: 1310-1319.
77. Moser R, Olgiati L, Patarroyo M, Fehr J. Chemotaxins inhibit neutrophil adherence to and transmigration across cytokine-activated endothelium: correlation to the expression of L-selectin. Eur J Immunol 1992; 23: 1481-1487.
78. Ley K, Baker J, Cybulsky M, Gimbrone M, Luscinskas F. Intravenous interleukin-8 inhibits granulocyte migration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. J Immunol 1993; 151: 6347-6357.
79. Westlin W, Kiely J, Gimbrone M. Interleukin-8 induces changes in human neutrophil actin conformation and distribution: relationship to inhibition of adhesion to cytokine-activated endothelium. J Leukocyte Biol 1992; 52: 43-51.
80. Rot A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol Today 1992; 13: 291-294.
81. Tanaka Y, Adams D, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993; 14: 111-115.
82. Schulz B, Michel G, Wagner S, et al. Increased expression of epidermal IL-8 receptor in psoriasis. J Immunol 1993; 151: 4399-4406.
83. Rot A. Binding of neutrophil attractant/activation protein-1 (interleukin-8) to resident dermal cells. Cytokine 1992; 4: 347.
84. Schönbeck U, Brandt E, Peterson F, Flad H, Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995; 154: 2375-2383.
85. Samanta A, Oppenheim J, Matsushima K. Identification and characterization of specific receptors for monocytederived neutrophil chemotactic factor (MDNCF) on human neutrophils. J Exp Med 1989; 169: 1185-1189.
86. Holmes W, Lee J, Kuang W, Rice G, Wood W. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253: 1278-1280.
87. Murphy P, Tiffany H. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253: 1280-1283.
88. Lee J, Horuk R, Rice R, Bennett G, Camerato T, Wood W. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 1992; 267: 16283-16287.
89. LaRosa G, Thomas K, Kaufman M, et al. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 1992; 267: 25402-25406.
90. Moser B, Barella L, Mattel S, et al. Expression of transcripts for two interleukin-8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 1993; 294: 285-292.
91. Chuntharapai A, Jin Kim K. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol 1995; 155: 2587-2594.
92. Hammond M, Lapointe G, Feucht P, et al. DL-8 induces neutrophil chemotaxis predominantly via type 1 IL-8 receptors. J Immunol 1995; 155: 1428-1433.
93. Horuk R, Chitnis C, Darbonne W, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261: 1182-1184.
94. Hadley T, Lu Z, Wasniowska K, et al. Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the duffy group antigen. J Clin Invest 1994; 94: 985-991.
95. Darbonne W, Rice G, Mohler M, et al. Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
96. Webb L, Ehrengruber M, dark-Lewis I, Baggiolini M, Rot A. Binding to heparan sulphate or heparin enhances neutrophil responses to IL-8. Proc Natl Acad Sci 1993; 90: 7158-7162.
97. Bettelheim K, Taylor J. A study of Escherichia coli isolated from chronic urinary tract infection. J Med Microbiol 1969; 2: 225-236.
98. Lidin-Janson G, Hanson L, Kaijser B. Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy school children. J Infect Dis 1977; 136: 346-353.
99. Plos K, Connell H, Jodal U, et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J infect Dis 1995; 171: 625-631.
100. Shahin R, Engberg I, Hagberg L, Svanborg-Edén C. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local Gram-negative infection. J Immunol 1987; 138: 3475-3480.
101. Hedges S, Anderson P, Lidin-Janson G, de Man P, Svanborg C. Interleukin-6 response to deliberate colonization of the human urinary tract with Gram-negative bacteria. Infect Immunol 1991; 59: 421-427.
102. Kunin C. Detection, prevention and management of urinary tract infections. Philadelphia, USA, Lea and Feiger, 1987.
103. Leffler H, Svanborg-Edén C. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 1980; 8: 127-134.
104. Breimer M, Hansson G, Leffler H. The specific glycosphingolipid composition of human urethral epithelial cells. J Biochem 1985; 98: 1169-1180.
105. Lindberg F, Lund B, Normark S. Genes of pyelonephritogenic Escherichia coli required for digalactoside specific agglutination of human cells. EMBO J 1984; 3: 1167-1173.
106. Marklund B. Structural and functional variation among Galα1-4Galβ adhesins of Escherichia coli. Thesis, University of Umeå, 1991.
107. Johanson I, Lindstedt R, Svanborg C. The role of the pap and prs encoded adhesins in Escherichia coli adherence to human epithelial cells. Infect Immun 1992; 60: 3416-3422.
108. Lindstedt R, Larson G, Falk P, Jodal U, Leffler H, Svanborg-Edén C. The receptor repertoire defines the host range for attaching Escherichia coli recognizing globo-A. Infect Immun 1991; 59: 1086-1092.
109. Lund B, Marklund B-I, Strömberg N, Lindberg F, Karlsson K, Normark S. Uropathogenic Escherichia coli can express serologically identical pill of different receptor-binding specificities. Mol Microbiol 1988; 2: 255-263.
110. Strömberg N, Marklund B-I, Lund B, et al. Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Galα-4Galβ-containing isoreceptors. EMBO J 1990; 9: 2001-2010.
111. Krogfelt K, Bergmans H, Klemm P. Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun 1990; 58: 1995-1998.
112. Giampapa C, Abraham S, Chiang T, Beachey E. Isolation and characterization of a receptor for type 1 fimbriae of Escherichia coli from guinea-pig erythrocytes. J Biol Chem 1988; 263: 5362-5367.
113. Wold A, Mestecky J, Tomana M, et al. Secretory immunoglobulin-A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun 1990; 58: 3073-3077.
114. Duguid J, Smith I, Dempster G, Edmunds P. Nonflagellar filamentous appendages ("fimbriae") and haemagglutinating activity in Bacterium coli. J Pathol Bacteriol 1955; 70: 335-348.
115. Bar-Shavit Z, Ofek I, Goldman G, Mirelman D, Sharon N. Mannose residues on phagocytes as receptors for the attachment of Escherichia coli and Salmonella typhi. Biochem Biophys Res Commun 1977; 78: 455-460.
116. Ofek I, Mirelman D, Sharon N. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature 1977; 265: 623-625.
117. Sokurenko E, Courtney H, Abraham S, Klemm P, Hasty D. Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect Immun 1992; 60: 4709-4719.
118. Sokurenko E, Courtney H, Ohman D, Klemm P, Hasty D. FimH family of type 1 fimbriae adhesins: functional heterogeneity due to minor sequence variations among fimH genes. J Bacteriol 1994; 176: 748-755.
119. Hedges S, de Man P, Linder H, van Kooten C, Svanborg-Edén C. Interleukin-6 is secreted by epithelial cells in response to Gram-negative bacterial challenge. In: Macdonald T, ed. Advances in Mucosal Immunology. International Conference of Mucosal Immunity, London, Kluwer, 1990; pp. 144-148.
120. Hedges S, Svensson M, Svanborg C. Interleukin-6 response of epithelial cell lines to bacterial stimulation in vitro. Infect Immun 1992; 60: 1295-1301.
121. Svensson M, Lindstedt R, Radin N, Svanborg C. Epithelial glycosphingolipid expression as a determinant of bacterial adherence and cytokine production. Infect Immun 1994; 62: 4404-4410.
122. Agace W, Hedges S, Ceska M, Svanborg C. IL-8 and the neutrophil response to mucosal Gram-negative infection. J Clin Invest 1993; 92: 780-785.
123. Agace W, Hedges S, Andersson U, Andersson J, Ceska M, Svanborg C. Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun 1993; 61: 602-609.
124. Hedges S, Agace W, Svensson M, Sjögren A-C, Ceska M, Svanborg C. Uroepithelial cells are a part of a mucosal cytokine network. Infect lmmun 1994; 62: 2315-2321.
125. Hedlund M, Svensson M, Nilsson Å, Duan R, Svanborg C. Role of the ceramide signalling pathway in cytokine responses to P fimbriated Escherichia coli. J Exp Med 1996; 183: 1037-1044.
126. Hedges S, Agace W, Svanborg C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol 1995; 3: 266-270.
127. Massion PP, Inoue H, Richman-Eisenstat J, et al. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest 1994; 93: 26-32.
128. DiMango E, Zar H, Bryan R, Prince A. Diverse P. aeroginosa gene products stimulate respiratory epithelial cells to produce IL-8. J Clin Invest 1995; 96: 2204-2210.
129. Eckmann L, Kagnoff MF, Fierer J. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 1993; 61: 4569-4574.
130. Huang J, O'Toole P, Doig P, Trust T. Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun 1995; 63: 1732-1738.
131. Sharma S, Tummuru M, Miller G, Blaser M. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun 1995; 63: 1681-1687.
132. Standiford T, Kunkel S, Basha M, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J Clin Invest 1990; 86: 1945-1953.
133. Crestani B, Comillet P, Dehoux M, Rolland C, Guenounou M, Aubier M. Alveolar type II epithelial cells produce interleukin 6 in vitro and in vivo. J Clin Invest 1994; 94: 731-740.
134. Pugin J, Schürer M, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci 1993; 90: 2744-2748.
135. Anderson P, Engberg I, Lidin-Janson G, et al. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect lmmun 1991; 59: 2915-2921.
136. Ko YC, Mukaida N, Ishiyama S, et al. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun 1993; 61: 1307-1314.
137. Benson M, Jodal U, Agace W, et al. Interleukin-6 and interleukin-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis 1996; (in press).
138. Tullus K, Fituri O, Burman L, Wretlind B, Brauner A. Interleukin-6 and interleukin- 8 in the urine of children with acute pyelonephritis. Pediatr Nephrol 1994; 8: 280-284.
139. Oishi K, Sonoda F, Kobayashi S, et al. Role of IL-8 and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994; 62: 4145-4152.
140. Crabtree JE, Wyatt JI, Trejdosiewicz LK, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994; 47: 61-66.
141. Raqib R, Lindberg A, Wretlind B, Bardhan P, Andersson U, Andersson J. Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun 1995; 63: 289-296.
142. Agace W, Patarroyo M, Svensson M, Carlemalm E, Svanborg C. Escherichia coli induce transuroepithelial neutrophil migration by an ICAM-1 dependent mechanism. Infect Immun 1995; 63: 4045-4062.
143. Agace W, Godaly G, Proudfoot A, Hedges S, Svanborg C. Escherichia coli induced transepithelial migration is IL-8 dependent. (Submitted).
144. Richtman-Eisenstat J, Jorens P, Hébert C, Ueki I, Nadel J. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway disease. Am J Physiol 1993; 264: L413-L418.
145. Tosi M, Stark J, Hemedani A, Gruenert D, Infeld M. Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines: effects on neutrophil-epithelial cell adhesion. Am J Respir Cell Mol Biol 1992; 7: 214-221.
146. Kvale D, Krajci P, Brandtzaeg P. Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol 1992; 35: 669-676.
147. Hill P, Lan H, Nikolic-Paterson D, Atkins R. Pulmonary expression of ICAM-1 and LFA-1 in experimental Goodpasture's syndrome. Am J Pathol 1994; 145: 220-227.
148. Ishikura H, Takahashi C, Kanagawa K, Hirata H, Imai K, Yoshiki T. Cytokine regulation of ICAM-1 expression on human renal tubular epithelial cells in vitro. Transplantation 1991; 51: 1272-1275.
149. Jackson A, Alexandrov A, Prescott S, James K, Chisholm G. Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor. J Urol 1992; 148: 1583-1586.
150. Elgavish A. Effects of Escherichia coli and E. coli LPS on the function of human ureteral epithelial cells cultured in serum-free medium. Infect Immnun 1993; 61: 3304-3312.
151. Liebert M, Wedemeyer G, Stein J, et al. Evidence for urothelial cell activation in interstitial cystitis. J Immunol 1993; 149: 470-475.
152. Bruijn J, Dinklo N. Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest 1993; 69: 329-335.
153. Minervini R, Panichi V, Vigano L, et al. Cellular expression of lymphocyte function antigen-1 and intercellular adhesion molecule-1 in normal kidney structures and in renal cancer. Eur Urol 1994; 26: 103-106.
154. Bechtel U, Scheur R, Landgraf R, König A, Feucht H. Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Transplantation 1994; 58: 905-911.
155. Jackson A, Alexandroff A, McIntyre M, Esuvaranathan K, James K, Chisholm G. Induction of ICAM-1 expression on bladder tumours by BCG immunotherapy. J Clin Pathol 1994; 47: 309-312.
156. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg-Eden C. Difference in susceptibility to Gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 1984; 46: 839-844.
157. de Man P, Van Kooten C, Aarden L, Engberg I, Svanborg-Edén C. Interleukin-6 induced by Gram-negative bacterial infection at mucosal surfaces. Infect Immun 1989; 57: 3383-3388.
158. Barber S, Perera P, Vogel S. Defective ceramide response in C3H/HeJ (Lpsd) macrophages. J Immunol 1995; 155: 2302-2305.
159. Agace W, Hedges S, Svanborg C. Lps genotype in the C57 black mouse background and its influence on the interleukin-6 response to E. coli urinary tract infection. Scand J Immunol 1997; 35: 531-538.
160. Linder H, Engberg I, van Kooten C, de Man P, Svanborg-Edén C. Effects of anti-inflammatory agents on mucosal inflammation induced by Gram-negative infection. Infect Immun 1990; 58: 2056-2060.
161. Miller T, Finden G, Cawley S. Cellular basis of host defence in pyelonephritis. III. Deletion of individual components. Br J Exp Path 1987; 68: 377-388.